Literature DB >> 18537543

Amyloidogenesis of natively unfolded proteins.

Vladimir N Uversky1.   

Abstract

Aggregation and subsequent development of protein deposition diseases originate from conformational changes in corresponding amyloidogenic proteins. The accumulated data support the model where protein fibrillogenesis proceeds via the formation of a relatively unfolded amyloidogenic conformation, which shares many structural properties with the pre-molten globule state, a partially folded intermediate first found during the equilibrium and kinetic (un)folding studies of several globular proteins and later described as one of the structural forms of natively unfolded proteins. The flexibility of this structural form is essential for the conformational rearrangements driving the formation of the core cross-beta structure of the amyloid fibril. Obviously, molecular mechanisms describing amyloidogenesis of ordered and natively unfolded proteins are different. For ordered protein to fibrillate, its unique and rigid structure has to be destabilized and partially unfolded. On the other hand, fibrillogenesis of a natively unfolded protein involves the formation of partially folded conformation; i.e., partial folding rather than unfolding. In this review recent findings are surveyed to illustrate some unique features of the natively unfolded proteins amyloidogenesis.

Mesh:

Substances:

Year:  2008        PMID: 18537543      PMCID: PMC2719783          DOI: 10.2174/156720508784533312

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  378 in total

Review 1.  Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.

Authors:  M Goedert
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

Review 2.  Structural disorder throws new light on moonlighting.

Authors:  Peter Tompa; Csilla Szász; László Buday
Journal:  Trends Biochem Sci       Date:  2005-09       Impact factor: 13.807

3.  Structure and dynamics of micelle-bound human alpha-synuclein.

Authors:  Tobias S Ulmer; Ad Bax; Nelson B Cole; Robert L Nussbaum
Journal:  J Biol Chem       Date:  2004-12-22       Impact factor: 5.157

4.  Merozoite surface protein 2 of Plasmodium falciparum: expression, structure, dynamics, and fibril formation of the conserved N-terminal domain.

Authors:  Andrew Low; Indu R Chandrashekaran; Christopher G Adda; Shenggen Yao; Jennifer K Sabo; Xuecheng Zhang; Alfreda Soetopo; Robin F Anders; Raymond S Norton
Journal:  Biopolymers       Date:  2007-09       Impact factor: 2.505

5.  Alpha-lactalbumin forms a compact molten globule in the absence of disulfide bonds.

Authors:  C Redfield; B A Schulman; M A Milhollen; P S Kim; C M Dobson
Journal:  Nat Struct Biol       Date:  1999-10

6.  Structural mobility of the human prion protein probed by backbone hydrogen exchange.

Authors:  L L Hosszu; N J Baxter; G S Jackson; A Power; A R Clarke; J P Waltho; C J Craven; J Collinge
Journal:  Nat Struct Biol       Date:  1999-08

Review 7.  Synucleinopathies: clinical and pathological implications.

Authors:  J E Galvin; V M Lee; J Q Trojanowski
Journal:  Arch Neurol       Date:  2001-02

8.  Localization of phosphoneuroprotein 14 (PNP 14) and its mRNA expression in rat brain determined by immunocytochemistry and in situ hybridization.

Authors:  S Nakajo; S Shioda; Y Nakai; K Nakaya
Journal:  Brain Res Mol Brain Res       Date:  1994-11

9.  The microtubule-associated protein tau forms a triple-stranded left-hand helical polymer.

Authors:  G C Ruben; K Iqbal; I Grundke-Iqbal; H M Wisniewski; T L Ciardelli; J E Johnson
Journal:  J Biol Chem       Date:  1991-11-15       Impact factor: 5.157

10.  Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease.

Authors:  K Uéda; H Fukushima; E Masliah; Y Xia; A Iwai; M Yoshimoto; D A Otero; J Kondo; Y Ihara; T Saitoh
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

View more
  60 in total

1.  Chain collapse of an amyloidogenic intrinsically disordered protein.

Authors:  Neha Jain; Mily Bhattacharya; Samrat Mukhopadhyay
Journal:  Biophys J       Date:  2011-10-05       Impact factor: 4.033

2.  Suppression, disaggregation, and modulation of γ-Synuclein fibrillation pathway by green tea polyphenol EGCG.

Authors:  Sneha Roy; Rajiv Bhat
Journal:  Protein Sci       Date:  2018-12-20       Impact factor: 6.725

Review 3.  Structural determinants of protein folding.

Authors:  Tse Siang Kang; R Manjunatha Kini
Journal:  Cell Mol Life Sci       Date:  2009-04-15       Impact factor: 9.261

4.  Single molecule characterization of α-synuclein in aggregation-prone states.

Authors:  Adam J Trexler; Elizabeth Rhoades
Journal:  Biophys J       Date:  2010-11-03       Impact factor: 4.033

5.  Unusual biophysics of immune signaling-related intrinsically disordered proteins.

Authors:  Alexander B Sigalov
Journal:  Self Nonself       Date:  2010-10

Review 6.  More than Just a Phase: Prions at the Crossroads of Epigenetic Inheritance and Evolutionary Change.

Authors:  Anupam K Chakravarty; Daniel F Jarosz
Journal:  J Mol Biol       Date:  2018-07-19       Impact factor: 5.469

7.  Advances in translational bioinformatics: computational approaches for the hunting of disease genes.

Authors:  Maricel G Kann
Journal:  Brief Bioinform       Date:  2009-12-10       Impact factor: 11.622

8.  Guiding protein aggregation with macromolecular crowding.

Authors:  Larissa A Munishkina; Atta Ahmad; Anthony L Fink; Vladimir N Uversky
Journal:  Biochemistry       Date:  2008-07-30       Impact factor: 3.162

9.  Computational modeling of the relationship between amyloid and disease.

Authors:  Damien Hall; Herman Edskes
Journal:  Biophys Rev       Date:  2012-09

10.  The role of intrinsically unstructured proteins in neurodegenerative diseases.

Authors:  Swasti Raychaudhuri; Sucharita Dey; Nitai P Bhattacharyya; Debashis Mukhopadhyay
Journal:  PLoS One       Date:  2009-05-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.